About Taurus Biosciences
Taurus Biosciences is a company based in San Diego (United States) founded in 2018 was acquired by Ligand Pharmaceuticals in September 2020. Taurus Biosciences offers products and services including OmniRat, OmniMouse, OmniChicken, Omni dAb, and Bispecific Platforms. Taurus Biosciences operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Omniab, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Ligand Pharmaceuticals
(Sep 10, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Taurus Biosciences
Taurus Biosciences offers a comprehensive portfolio of products and services, including OmniRat, OmniMouse, OmniChicken, Omni dAb, and Bispecific Platforms.
Platform for generating human antibodies using transgenic rats
Transgenic mouse system for antibody discovery and optimization
Transgenic chicken for producing humanized single-domain antibodies
Technology for diverse antibody repertoires against conserved antigens
Tools for developing bispecific antibodies for therapeutic applications
Funding Insights of Taurus Biosciences
Detailed funding history for Taurus Biosciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Taurus Biosciences
Taurus Biosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ligand Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical drugs are manufactured and developed in the United States.
|
Locked | Locked | Locked |
Investor details for Taurus Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Taurus Biosciences
Investment portfolio details for Taurus Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Taurus Biosciences
Detailed financials for Taurus Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Taurus Biosciences Comparisons
Peer comparison for Taurus Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Taurus Biosciences
Taurus Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Taurus Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Taurus Biosciences
Complete news archive for Taurus Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Taurus Biosciences
Taurus Biosciences was founded in 2018.
Taurus Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Taurus Biosciences was founded in 2018 in San Diego, United States, within the biotechnology sector. Novel cow antibodies are discovered and developed, with intellectual property held on ultralong CDR3s and humanized versions. These engineered antibodies are applied to bind multiple antigens and target ion channels for autoimmune disease and cancer therapeutics. Support is provided for the study and development of cow-based monoclonal antibodies.
Taurus Biosciences's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Taurus Biosciences offers OmniRat, OmniMouse, OmniChicken, Omni dAb, and Bispecific Platforms.
Taurus Biosciences has 1 investor. Key investors include Ligand Pharmaceuticals.